Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival
2008 · BMC Gastroenterology · 127 citations
https://doi.org/10.1186/1471-230x-8-56
M
Mikinori Sato
Merck (Japan)(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
1.7K
Citations
21
h-index
29
i10-index
Mikinori Sato is an academic researcher from Merck (Japan). The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Colorectal Cancer Surgical Treatments & Cell Adhesion Molecules Research. The author has an h-index of 21, co-authored 77 publications.
Papers by this author
worksThe stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
2006 · Molecular Cancer · 91 citations
https://doi.org/10.1186/1476-4598-5-46
Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases
2007 · World Journal of Surgical Oncology · 24 citations
https://doi.org/10.1186/1477-7819-5-79
Inflammatory pseudotumor of the liver diagnosed as metastatic liver tumor in a patient with a gastrointestinal stromal tumor of the rectum: report of a case
2014 · World Journal of Surgical Oncology · 20 citations
https://doi.org/10.1186/1477-7819-12-140
1996P Primary analysis of post-marketing surveillance (PMS) data for avelumab maintenance therapy in patients (pts) with curatively unresectable urothelial carcinoma (UC) in Japan
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.2082
279P Avelumab maintenance therapy in older patients with advanced urothelial carcinoma in Japan: Subgroup analyses of data from post-marketing surveillance by age group
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.10.299
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat